UniCredit Kepler Cheuvreux 21st German Corporate Conference

17-18 January 2022

Safe Harbor Statement

This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing.

Fresenius does not undertake any responsibility to update the forward-looking statements contained in this presentation.

UniCredit Kepler Cheuvreux 21st German Corporate Conference, 17-18 January 2022 © Fresenius SE & Co. KGaA Investor Relations & Sustainability

2

Company Overview 02 03 04

Agenda

01

02

03

04

Business Update

Financials Q3/21

Attachments

Company

Q3/21

& Outlook

Overview

UniCredit Kepler Cheuvreux 21st German Corporate Conference, 17-18 January 2022 © Fresenius SE & Co. KGaA Investor Relations & Sustainability

3

Company Overview 02 03 04

A Global Leader in Health Care Products and Services

in sales (FY/2020)

€ 36.3 bn

Global presence in 100+

countries

Leading market

#1 positions

Long-term opportunities in growing, non-cyclicalmarkets

100 +

Employees

worldwide

(as of September 30,

2021) 314,000+

Strong financial performance and cash flow generation

UniCredit Kepler Cheuvreux 21st German Corporate Conference, 17-18 January 2022 © Fresenius SE & Co. KGaA Investor Relations & Sustainability

4

Company Overview 02 03 04

Investment Highlights

Diversified healthcare Group

Leading positions in

Resilient business model

with four strong business

growing non-cyclical

based on megatrends

segments

markets

healthcare and demographics

Purpose-driven business

Strong financial

Reliable

delivers sustainable

performance and cash

dividend growth

contribution to society

flow generation

UniCredit Kepler Cheuvreux 21st German Corporate Conference, 17-18 January 2022 © Fresenius SE & Co. KGaA Investor Relations & Sustainability

5

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Fresenius SE & Co. KGaA published this content on 03 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 January 2022 14:50:00 UTC.